As shown in Fig. 7D, ZIC2 overexpression induced the tumor growth of MC38 xenografts in vivo, and the addition of pexidartinib abrogates this induction (Fig. 7D), suggesting that ZIC2 augmented NPC tumorigenesis in vivo through MCSF secretion. The gene discussed is ZIC2; the disease is neoplasm.